Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DB25FWYJX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,188
Award facts
- Contract value 100% obligated
- $3,188.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 3, 2025, for the supply of Xolair 300 mg/2 ml auto-injector units valued at $3,188.32, with final delivery due by July 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains an extensive portfolio of federal contracts with the Defense Logistics Agency and its Medical Supply Chain, supplying a broad range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's demonstrated capability to meet federal procurement requirements through open competition and its established relationship with DLA's medical supply infrastructure position it as a critical vendor for pharmaceutical procurement. The Xolair delivery order represents a routine transaction within the company's ongoing support of federal medical supply needs across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FWYJX?
SPE2DB25FWYJX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 3, 2025.
How much is contract SPE2DB25FWYJX worth?
The government has obligated $3,188 on SPE2DB25FWYJX.
Is contract SPE2DB25FWYJX an order under another contract?
Yes. SPE2DB25FWYJX is a delivery order under SPE2DB25D3012, an indefinite delivery contract.
Was contract SPE2DB25FWYJX competed?
The extent of competition for SPE2DB25FWYJX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award